Canadian Cancer Trials Group
Platinum-Based Drug(Canadian Cancer Trials Group)은 Non-small Cell Lung Cancer Stage III 표적 치료제로, Lung Cancer Metastatic 영역에서 개발·상용화 중입니다. 작용기전: targets of S1PR1 but raise the possibility that S1PR1-induced engagement of Wnt signaling. Phase 2에서 효능·안전성 신호를 검증 중입니다. 대표 임상 효능: ORR 35.1% (ClinicalTrials.gov NCT01523457). 차별점: novel form of copper–dependent cell death regulated through mitochondrial pathways, represents a promising strategy to.
Non-small Cell Lung Cancer Stage III
Lung Cancer Metastatic
Recruiting
vedotin plus pembrolizumab in advanced urotheli
novel form of copper–dependent cell death regulated through mitochondrial pathways, represents a promising strategy to
targets of S1PR1 but raise the possibility that S1PR1-induced engagement of Wnt signaling
apoptosis/necrosis staining imaging, ROS staining imaging, copper ion imaging, mitochondrial co-localization imaging, mitochondri
biomarkers in several malignancies; however, their role in patients receiving avelumab maintenance for advanc
Resistance to platinum-based drugs represents a significant challenge in the clinical treatment of esophageal cancer
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
Canadian Cancer Trials Group
Platinum-Based Drug(Canadian Cancer Trials Group)은 Non-small Cell Lung Cancer Stage III 표적 치료제로, Lung Cancer Metastatic 영역에서 개발·상용화 중입니다. 작용기전: targets of S1PR1 but raise the possibility that S1PR1-induced engagement of Wnt signaling. Phase 2에서 효능·안전성 신호를 검증 중입니다. 대표 임상 효능: ORR 35.1% (ClinicalTrials.gov NCT01523457). 차별점: novel form of copper–dependent cell death regulated through mitochondrial pathways, represents a promising strategy to.
Non-small Cell Lung Cancer Stage III
Lung Cancer Metastatic
Recruiting
vedotin plus pembrolizumab in advanced urotheli
novel form of copper–dependent cell death regulated through mitochondrial pathways, represents a promising strategy to
targets of S1PR1 but raise the possibility that S1PR1-induced engagement of Wnt signaling
apoptosis/necrosis staining imaging, ROS staining imaging, copper ion imaging, mitochondrial co-localization imaging, mitochondri
biomarkers in several malignancies; however, their role in patients receiving avelumab maintenance for advanc
Resistance to platinum-based drugs represents a significant challenge in the clinical treatment of esophageal cancer
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.